Position in BIIB
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$144,982,312
+$44,240,534 QoQ
Shares Held
790,827
+38.2% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Amundi holds $19,301,385,364 across 13 Drug Manufacturers - General names. BIIB ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,055,025 | $4,649,460,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,406,820 | $3,277,163,076 | |
| 3 | AZN |
Astrazeneca PLC
|
15,386,149 | $3,034,456,300 | |
| 4 | ABBV |
AbbVie Inc.
|
10,698,095 | $2,326,728,674 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,764,954 | $1,655,786,310 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,539,111 | $1,468,835,897 | |
| 7 | AMGN |
Amgen Inc
|
3,377,306 | $1,188,305,111 | |
| 8 | PFE |
Pfizer Inc
|
40,825,470 | $1,146,379,191 |
All Filings in BIIB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $144,982,312 | 790,827 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $100,741,778 | 572,429 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $86,612,723 | 618,309 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $72,816,704 | 579,797 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $180,074,181 | 1,315,947 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $186,102,102 | 1,216,990 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $173,973,720 | 897,512 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $158,754,968 | 684,820 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $212,568,479 | 985,802 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $310,965,455 | 1,201,706 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $281,046,596 | 1,093,524 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $338,206,100 | 1,187,313 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $160,782,797 | 578,293 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $226,695,844 | 818,633 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $173,255,232 | 648,896 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,173,863 | 407,835 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $73,132,110 | 347,256 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $192,798,263 | 803,594 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $241,957,295 | 855,003 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $214,582,818 | 619,698 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||